Josef Eberle

2.7k citations
78 papers · 1.6k indexed · h-index 21
  • Virology top 0.5%
    • HIV Research and Treatment 44
    • HIV/AIDS drug development and treatment 35
    • HIV/AIDS Research and Interventions 23
  • Hepatology top 10%
    • Hepatitis C virus research 11
  • Immunology top 10%
    • T-cell and Retrovirus Studies 7
  • Epidemiology top 10%
    • Herpesvirus Infections and Treatments 7
    • Hepatitis B Virus Studies 5
    • HIV-related health complications and treatments 6

Josef Eberle

73 papers receiving 1.6k citations

Peers

Josef Eberle
Comparison fields: 5 of 91
  • Virology 1.1k
  • Infectious Diseases 979
  • Hepatology 109
  • Immunology 258
  • Epidemiology 343
Replace Masanori Kameoka with:
Masanori Kameoka Japan
Michael B. Agy United States
Brigitte Beer United States
Jason B. Dinoso United States
Philip M. McKenna United States
Noortje M. van Maarseveen Netherlands
Erica N. Borducchi United States
Michael W. Cho United States
Jenna Rychert United States
Christy L. Lavine United States
Josef Eberle relative to Masanori Kameoka Japan Masanori Kameoka's profile →
Citations per field
00.5×1.5×
Masanori Kameoka · 1×
Citations per year

Countries citing papers authored by Josef Eberle

Since Specialization
Citations

This map shows the geographic impact of Josef Eberle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Eberle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Eberle more than expected).

Fields of papers citing papers by Josef Eberle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josef Eberle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Eberle. The network helps show where Josef Eberle may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Josef Eberle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Josef Eberle Line = papers co-authored together Josef Eberle links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20192
2 20164
3 20160
4 201413
5 20141
6 201424
7 20135
8 20129
9 20106
10 200644
11 200111
12 200023
13 199817
14 199844
15 199715
16 199626
17 199564
18 199529
19 199262
20 198935

About Josef Eberle

Josef Eberle is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 78 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (44 papers), HIV/AIDS drug development and treatment (35 papers), HIV/AIDS Research and Interventions (23 papers), Hepatitis C virus research (11 papers), T-cell and Retrovirus Studies (7 papers), Herpesvirus Infections and Treatments (7 papers), HIV-related health complications and treatments (6 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (979 citations) and Hepatology (109 citations). Josef Eberle has collaborated with scholars based in Germany, France and Cameroon. Frequent co-authors include Lutz Gürtler, Léopold Zekeng, Andreas Bültmann, L. Kaptué, Jürgen Haas, Brian Seed, Winfried Schraut, Steven L. Knapp, Pierre Hauser and Albrecht von Brunn. Their work appears in journals such as Medical Microbiology and Immunology, AIDS Research and Human Retroviruses, Infection, Clinical Infectious Diseases and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026